Biomedical Reports

Scope & Guideline

Empowering the scientific community through open access.

Introduction

Immerse yourself in the scholarly insights of Biomedical Reports with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2049-9434
PublisherSPANDIDOS PUBL LTD
Support Open AccessNo
CountryGreece
TypeJournal
Convergefrom 2014 to 2024
AbbreviationBIOMED REP / Biomed. Rep.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPOB 18179, ATHENS 116 10, GREECE

Aims and Scopes

Biomedical Reports aims to disseminate significant findings in the field of biomedical research, focusing on both clinical and laboratory studies that contribute to the understanding and treatment of diseases. The journal covers a diverse range of topics, emphasizing novel methodologies and interdisciplinary approaches to enhance healthcare outcomes.
  1. Clinical Applications and Case Studies:
    The journal frequently publishes case reports and clinical studies that provide insights into rare diseases, treatment methodologies, and patient management strategies.
  2. Molecular and Cellular Biology:
    Research articles explore the molecular mechanisms underlying various diseases, including cancer, neurodegenerative disorders, and infectious diseases, often utilizing advanced techniques such as genomics, proteomics, and metabolomics.
  3. Therapeutic Innovations and Drug Development:
    The journal showcases studies related to novel therapeutic agents, drug mechanisms, and clinical trials, highlighting advancements in pharmacology and treatment protocols.
  4. Immunology and Infectious Diseases:
    A significant emphasis is placed on understanding immune responses, infectious diseases, and the development of vaccines and immunotherapies.
  5. Biomarkers and Diagnostics:
    Research focusing on identifying new biomarkers for disease diagnosis, prognosis, and therapeutic response is a core area, facilitating personalized medicine approaches.
  6. Public Health and Epidemiology:
    The journal includes studies that address public health challenges, epidemiological trends, and the impact of health interventions on community health.
Recent publications in Biomedical Reports indicate a notable evolution in research themes, with various emerging trends reflecting current scientific interests and societal health challenges.
  1. COVID-19 Research:
    There has been a significant increase in studies related to COVID-19, focusing on its clinical management, epidemiology, long-term effects, and vaccine efficacy, reflecting the pandemic's impact on global health.
  2. Genomic and Precision Medicine:
    Emerging research in genomic medicine, including studies on genetic polymorphisms and their association with disease susceptibility, is increasingly prevalent as precision medicine gains traction.
  3. Microbiome Studies:
    The exploration of the human microbiome and its relation to various health conditions is gaining attention, indicating a shift towards understanding holistic health and disease mechanisms.
  4. Neuroimmunology:
    Research at the intersection of neuroscience and immunology is on the rise, reflecting growing interest in how immune responses affect neurological conditions and vice versa.
  5. Metabolomics and Biomarker Discovery:
    The trend towards metabolomics for biomarker discovery and disease characterization is emerging, enhancing the ability to diagnose and monitor diseases through metabolic profiling.
  6. Telemedicine and Digital Health Solutions:
    The integration of technology in healthcare, especially telehealth solutions, is increasingly discussed, driven by the necessity for remote patient management during and after the pandemic.

Declining or Waning

While Biomedical Reports continues to thrive in various research areas, some themes appear to be diminishing in prominence. This may reflect a shift in research focus or the saturation of certain topics within the biomedical field.
  1. Traditional Herbal Medicine:
    Although still relevant, the frequency of publications on traditional herbal remedies has decreased, possibly due to a growing emphasis on evidence-based approaches and synthetic pharmaceuticals.
  2. Basic Science without Clinical Correlation:
    There is a noticeable decline in purely basic science studies that lack direct clinical application, as the journal increasingly prioritizes research with immediate translational value.
  3. Animal Studies:
    Research involving animal models is less frequently published, which may indicate a shift towards human clinical studies and in vitro research that can directly inform patient care.
  4. Single-Factor Studies:
    The journal has moved away from studies that examine the effects of single factors in isolation, suggesting a preference for multifactorial analyses that better reflect the complexity of human health.
  5. Narrowly Focused Case Reports:
    The publication of case reports that address very niche or isolated conditions has decreased, as the journal seeks to highlight broader implications and findings that could benefit a wider audience.

Similar Journals

Archives of Clinical Infectious Diseases

Pioneering Research for Public Health Impact
Publisher: BRIEFLANDISSN: 2345-2641Frequency: 4 issues/year

Archives of Clinical Infectious Diseases is a peer-reviewed journal dedicated to advancing knowledge in the field of infectious diseases, published by BRIEFLAND in Iran. With a broad scope, it covers various aspects of cardiology, critical care, immunology, microbiology, public health, and toxicology, affirming its relevance in today's health landscape. Despite the lack of open access options, the journal maintains a strong reputation, reflected in its Q3 ranking in multiple categories within the 2023 category quartiles. The journal aims to provide a platform for researchers and practitioners to disseminate critical findings that can impact clinical practices and public health policies. Its commitment to rigorous peer review ensures that only high-quality research is published, thereby serving as an essential resource for professionals, students, and public health advocates. For those engaged in the ever-evolving world of infectious diseases, Archives of Clinical Infectious Diseases stands as a vital contribution to the medical literature.

EBioMedicine

Unlocking breakthroughs in biochemistry and medicine.
Publisher: ELSEVIERISSN: 2352-3964Frequency: 12 issues/year

EBioMedicine is an esteemed open-access journal published by ELSEVIER, dedicated to advancing the fields of biochemistry, genetics, and molecular biology, as well as medicine. Since its inception in 2014, EBioMedicine has established itself as a prominent platform for disseminating high-quality research, evidenced by its impressive rankings in Scopus, where it holds a Q1 category in both Biochemistry, Genetics and Molecular Biology and Medicine for 2023. With an exceptional impact factor that places it in the top percentiles (97th in Medicine and 93rd in Biochemistry), the journal is recognized for its rigorous peer-review process and its commitment to fostering scientific collaboration. Open access since its launch, EBioMedicine ensures that groundbreaking research is readily available to researchers, professionals, and students worldwide, enhancing knowledge dissemination and driving innovation in these crucial fields. For those seeking to stay at the forefront of biomedical research, EBioMedicine is an invaluable resource.

Biomedical Research and Therapy

Advancing biomedical knowledge through innovative research.
Publisher: BIOMEDPRESSISSN: 2198-4093Frequency: 12 issues/year

Biomedical Research and Therapy is a pioneering journal published by BIOMEDPRESS, dedicated to the field of biomedical sciences. With its ISSN 2198-4093, this journal aims to disseminate high-quality research and innovative therapies that advance knowledge in biomedical research. Although it operates on a non-open access model, it provides crucial insights into various topics such as drug discovery, disease mechanisms, regenerative medicine, and clinical applications. The journal's rigorous peer-review process ensures the publication of critical findings and methodologies, making it a vital resource for researchers, practitioners, and students interested in the constantly evolving landscape of biomedical research. With converged years from 2020 to 2024 and an emerging reputation in its field, Biomedical Research and Therapy is positioned to contribute significantly to the global scientific community, enriching the discourse around therapeutic advancements and biomedical innovations.

Journal of Biomedical Research

Elevating Biomedical Research Through Rigorous Scholarship
Publisher: NANJING MEDICAL UNIVISSN: 1674-8301Frequency: 6 issues/year

Journal of Biomedical Research, published by Nanjing Medical University in China, is a prominent platform for groundbreaking discoveries in the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine. With an ISSN of 1674-8301 and an E-ISSN of 1876-4819, the journal offers a vital opportunity for researchers, professionals, and students to disseminate insightful research findings. Although not currently available as an open access journal, its inclusion in the second quartile of both Biochemistry and Medicine categories underscores its growing influence and commitment to high-quality scholarship, as evidenced by its historical compliance with Scopus rankings prior to 2009. By fostering an interdisciplinary approach, the Journal of Biomedical Research aims to bridge gaps in current biomedical understanding and encourages innovative research that can lead to significant contributions in improving health outcomes. Its editorial policies guarantee rigorous peer review, making it a trusted source of knowledge in the biomedical community.

Cold Spring Harbor Molecular Case Studies

Exploring the nexus of genetics and biomedicine.
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 2373-2873Frequency: 6 issues/year

Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.

JOURNAL OF INVESTIGATIVE DERMATOLOGY

Unveiling the Mysteries of Dermatology
Publisher: ELSEVIER SCIENCE INCISSN: 0022-202XFrequency: 12 issues/year

JOURNAL OF INVESTIGATIVE DERMATOLOGY, published by Elsevier Science Inc, stands at the forefront of research in the fields of dermatology, biochemistry, cell biology, and molecular biology. With an impressive impact factor reflecting its Q1 ranking in Dermatology and Biochemistry, this journal provides a vital platform for disseminating groundbreaking research and innovative studies that drive forward our understanding of skin biology and disease. The journal has maintained a distinguished presence since its inception in 1945, successfully converging decades of scientific inquiry and expertise. It ranks among the top journals in medicine and dermatology, holding a remarkable 7th place out of 142 in the Scopus Medicine Dermatology category, signaling its influence and relevance in the academic community. Researchers, professionals, and students alike will find valuable insights into cutting-edge investigations and methodologies to advance their own studies in skin health and pathology. While the journal is not an open access publication, access options remain robust for institutions and individuals committed to the advancement of dermatological science.

Genome Medicine

Empowering Progress in the World of Genome Medicine
Publisher: BMCISSN: 1756-994XFrequency: 1 issue/year

Genome Medicine is a prestigious, peer-reviewed journal published by BMC, focusing on the rapidly evolving fields of genetics, molecular biology, and molecular medicine. Established in 2009 and boasting an open-access format, it has become a leading platform for disseminating high-quality research findings that advance our understanding of genetic diseases and therapeutic innovations. With an impressive Q1 ranking across multiple relevant categories—in particular, genetics (clinical), molecular biology, and molecular medicine—this journal is recognized for its substantial impact in the academic community, as evidenced by its exceptional placement in Scopus rankings. By providing unrestricted access to groundbreaking studies, Genome Medicine fosters collaboration and knowledge sharing among researchers, clinicians, and educators, thus playing a vital role in the transition from fundamental genetic research to clinical applications. Researchers are encouraged to contribute their findings and insights, further solidifying the journal’s position as a pivotal resource for those dedicated to advancing genomic medicine.

MOLECULAR ASPECTS OF MEDICINE

Illuminating the Pathways of Molecular Research
Publisher: ELSEVIERISSN: 0098-2997Frequency: 6 issues/year

MOLECULAR ASPECTS OF MEDICINE is a premier journal published by Elsevier, focusing on groundbreaking research in the fields of biochemistry, molecular biology, and medicine. With an impressive impact factor and ranking within the top quartile across multiple categories, including Q1 in Biochemistry, Clinical Biochemistry, and Molecular Medicine, it serves as an essential platform for sharing innovative findings that advance our understanding of molecular mechanisms in health and disease. The journal, which has been in publication since 1976, provides a diverse range of articles, addressing both fundamental and applied aspects of molecular medicine, thus appealing to a broad audience of researchers, professionals, and students. While MOLECULAR ASPECTS OF MEDICINE does not currently offer Open Access options, it remains a vital resource for accessing high-quality, peer-reviewed scholarly works that significantly contribute to the advancement of biomedical research.

Byulleten Sibirskoy Meditsiny

Unlocking Insights in Molecular Biology and Therapeutics
Publisher: SIBERIAN STATE MEDICAL UNIVISSN: 1682-0363Frequency: 6 issues/year

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

Journal of Pediatric Infectious Diseases

Empowering healthcare professionals with vital research.
Publisher: GEORG THIEME VERLAG KGISSN: 1305-7707Frequency: 4 issues/year

Journal of Pediatric Infectious Diseases, published by GEORG THIEME VERLAG KG, serves as a vital platform for the dissemination of cutting-edge research in the fields of pediatric infectious diseases and related areas. With an ISSN of 1305-7707 and an E-ISSN of 1305-7693, this journal endeavors to address critical issues and innovations in pediatric medicine, fostering an understanding of infectious diseases that affect children. The journal is indexed in Scopus, where it holds a Q4 ranking in both Infectious Diseases and Pediatrics, Perinatology and Child Health, reflecting its emerging status within medical research. Although currently not open access, it offers valuable insights and empirical research crucial for healthcare professionals, researchers, and students dedicated to improving pediatric care. The Journal of Pediatric Infectious Diseases not only highlights contemporary challenges faced by pediatric health practitioners but also aims to be a cornerstone for future developments in the management and prevention of infections in young populations.